Caring for Diverse Populations: What You Need to Know About Your LGBTQI Patients
Cancer Prevention and Control at the WVU Cancer Institute presents Mandi Chapman, MA discussing cultural sensitivity for LGBTQI patients in this newly created web course. As the Associate Center Director, Patient-Centered Initiatives and Health Equity for the George Washington Cancer Center, Ms. Chapman’s research focuses on patient navigation, cancer survivorship and health equity for lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) communities. Originally recorded at the WVU Health Sciences Center, the presentation:
- Describes national requirements for nondiscrimination of LGBTQ patients.
- Explains behavioral health risks and system challenges for LGBTQ patients.
- Describes and utilizes language that is accurate and affirming for LGBTQ patients.
- Identifies ways to create a welcoming environment for LGBTQ patients.
You can view the presentation.
Contact Cancer Prevention and Control at 304-293-2370 or email@example.com with any questions or comments.
Defense Health Program
The WVU Cancer Institute is applying for a Certificate of Need with the West Virginia Health Care Authority for a mobile lung cancer screening program, which will be called LUCAS. This program would increase access to screening for patients in rural areas and address the growing demand for cancer services in the state.
WVU Medicine Physician Presents at International Society of Intraoperative Radiation Therapy Conference
Christopher P. Cifarelli, M.D., Ph.D., Director of the WVU Medicine Gamma Knife program and member of the WVU Cancer Institute Research Programs, presented a talk on his team’s research during the 2018 ISIORT conference in Mannheim, Germany. Dr. Cifarelli presented two sessions: Feasibility of Dose Escalation Using Intraoperative Radiotherapy Following Resection of Large Brain Metastases Compared to Post-operative SRS and Neurosurgical Nuances of IORT for Intracranial Lesions. The work focuses on a novel use of radiation delivered to the brain at the time of surgery as a means to decrease long-term radiation doses and improve overall outcomes for patients with metastatic and primary brain tumors. The conference had about 300 specialists from over 20 nations in attendance. Dr. Cifarelli is a faculty member in the WVU Department of Neurosurgery and a member of the Radiation Oncology team at WVU Cancer Institute. This work was co-authored by Joshua Hack MS, Geraldine M. Jacobson MD, and J. Austin Vargo MD.